Skip to content

A prospective cohort study on myasthenia gravis

A prospective registry study on myasthenia gravis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082337
Enrollment
Unknown
Registered
2024-03-26
Start date
2024-03-27
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myasthenia gravis

Interventions

Observational group of patients with myasthenia gravis (Administering standardized treatment protocols according to the guidelines for disease management):None

Sponsors

Neurology Department of Yunnan University Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with myasthenia gravis for the first time, presenting initially with only ocular symptoms during the early stages of the disease

Exclusion criteria

Exclusion criteria: 1.Patients without evident ocular myasthenia gravis symptoms at the initial onset of the disease 2.In addition to ocular myasthenia gravis, patients who develop generalized muscle weakness symptoms within one month of the initial onset of the disease 3.Patients with congenital or infantile myasthenia gravis 4.Other patients with active eye diseases similar to ocular myasthenia gravis, including thyroid eye disease and those with a history of eyelid-related surgeries

Design outcomes

Primary

MeasureTime frame
QMGS score;

Secondary

MeasureTime frame
Activities of Daily Living (ADL) assessment score";Myasthenia Gravis Activities of Daily Living Scale Score;Myasthenia Gravis Quality of Life 15-Item Scale Score;

Countries

China

Contacts

Public ContactYao Na

Yunnan University Affiliated Hospital

825509818@qq.com+86 186 8756 5892

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026